interactive
Physical
And
Cognitive
Exercise
System

iPACES™ is a neuro-exergame to impact brain health and wellness via a portable pedal-and-play technology designed for everyday use, including for patients and caregivers coping with challenges, from autism to Alzheimer's

About iPACES

iPACES LLC is developing an innovative solution to support brain health through combined physical and cognitive exercise. Our system, called iPACES (the interactive Physical and Cognitive Exercise System), is a “pedal-n-play” neuro-exergame designed to address cognitive challenges associated with a wide range of neurological conditions, from autism to Alzheimer’s disease. Research on iPACES as a prescriptive digital therapeutic (PdTx) has been supported by the National Institutes of Health (NIH), with a primary focus on improving cognition in older adults with mild cognitive impairment (MCI). As dementia cases continue to rise and no cure yet exists, behavioral interventions such as exercise have gained increasing attention for their ability to enhance brain health and help prevent or slow cognitive decline.

iPACES LLC continues to advance neuro-exergaming as a behavioral intervention for preventing and remediating cognitive decline from Alzheimer’s disease and related dementias (ADRDs), as well as for individuals with Parkinson’s disease (PD). The current (2025–2027) randomized clinical trial (RCT) of iPACES for Parkinson’s is funded by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) through the Small Business Innovation Research (SBIR) program. It is run from three sites: one in the Capital District area of Albany, NY; one on the North Shore of Boston, MA; and one in the greater Los Angeles region, CA. This trial aims to maximize the cognitive benefits of long-term exercise by integrating tailored mental challenges with physical activity, targeting specific cognitive difficulties experienced by people with Parkinson’s.

The iPACES software is designed to be flexible — researchers can adjust in-app challenge levels and cognitive task settings to match each participant’s cognitive ability and study condition. The system supports a bring-your-own-device (BYOD) model, allowing participants to use their own smartphone or tablet with any recumbent pedaler, whether at home or in a community gym. Digital features such as virtual coaching, engaging visual environments, in-game rewards, notifications, and remote data collection via smartphones and wearable devices (e.g., smartwatches) help promote engagement and adherence.

Participants in our current studies engage with iPACES three to five times per week for one year. Our studies compare cognitive and biomarker outcomes across multiple time points, examining the effects of different intensities and types of mental exercise. Following investigation, iPACES LLC plans to prepare results for scientific publication and, pending FDA review, pursue commercialization of iPACES as an empirically supported, prescriptible digital therapeutic (PdTx). The goal is to make iPACES available as a clinically validated tool that physicians and healthcare providers can use to support cognitive health in neurological conditions.

  • Dr. Cay Anderson-Hanley

    Neuropsychologist

  • Dr. Paul Arciero

    Applied Physiology and Nutrition Scientist

  • John Arciero

    COO

  • Dr. Tobi Saulnier

    1st Playable

Frequently asked questions

Can’t find the answer you’re looking for? Reach out to us at info@myipaces.org

What does iPACES do?

iPACES is developing a neuro-exergame for use in clinical research.

Where is the current iPACES study located?

Our current study is a completely remote study.

Will I have to pay for the iPACES equipment?

No, we provide it to you free of charge.

Recent publications and featured articles

iPACES principals have been published in leading scientific journals and publications in recent years.

Clinical Interventions in Aging

The interactive Physical and Cognitive Exercise System (iPACES): effects of a 3-month in-home pilot clinical trial for mild cognitive impairment and caregivers

Background: Alzheimer’s and related dementias are on the rise, and older adults and their families are seeking accessible and effective ways to stave off or ameliorate mild cognitive impairment (MCI). Aim: This pilot clinical trial (ClinicalTrials.gov Identifier: 03069391) examined neuropsychological and neurobiological outcomes of interactive physical and mental exercise. Participants and methods: Older adults (MCI and caregivers) were enrolled in a 3-month, in-home trial of a portable neuro-exergame (the interactive Physical and Cognitive Exercise System [iPACESTM]), in which they pedaled and steered along a virtual bike path to complete a list of errands (Memory LaneTM). Neuropsychological function and salivary biomarkers were measured at pre-, mid-, and posttrial. Ten older adults complied with the recommended use of iPACES (complete dose; $2×/wk, 67% of the 15 who also had pre- and postevaluation data). Statistical analyses compared change over time and also change among those with a complete dose vs inadequate dose. Correlations between change in neuropsychological and biomarker measures were also examined. Results: Executive function and verbal memory increased after 3 months (p = 0.01; no significant change was found with an inadequate dose). Change in salivary biomarkers was moderately associated with increasing cognition (cortisol, r = 0.68; IGF-1, r = 0.37). Conclusion: Further research is needed, but these pilot data provide preliminary indications to suggest neuro-exergaming can impact cognitive function, perhaps via neurobiological mechanisms, and as such may provide an effective and practical way to promote healthy aging.

Journal of Clinical Medicine

The Enhanced Interactive Physical and Cognitive Exercise System (iPACES v2.0): Pilot Clinical Trial

Abstract: Given increasing longevity worldwide, older adults and caregivers are seeking ways to curb cognitive decline especially for those with mild cognitive impairment (MCI, now mild neurocognitive disorder, mNCD, Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-V). This quasi-experimental, within-subjects pilot clinical trial was designed to replicate and extend the study of cognitive benefits for MCI by improving upon our prior interactive Physical and Cognitive Exercise Study (iPACES v1.0) by increasing the usability of the neuro-exergame and exploring possible underlying neurobiological mechanisms. Older adults were enrolled in a three-month, in-home trial of a portable neuro-exergame (iPACES™ v2.0) where participants pedaled and steered along a virtual bike path (Memory Lane™). Neuropsychological function was assessed at baseline after component familiarization intervals (e.g., two weeks of exercise-only, game-only, etc.) and after three months of interactive neuro-exergame intervention. Fourteen participants were enrolled in the study and seven completed the final evaluation. Intent-to-treat analyses were conducted with imputed missing data (total n = 14). Significant improvement in executive function (Stroop) was found (d = 0.68, p = 0.02) only. Changes in salivary biomarkers (cortisol and insulin-like growth factor 1; IGF-1) were significantly associated with improved cognition. Further research is needed, but pilot data suggest that a portable in-home neuro-exergame may be an additional, practical tool to fight back against cognitive decline and dementia.

Informational Material

Feel free to download and share!